Risk of Infection Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Clinical Lymphoma, Myeloma and Leukemia - Tập 20 - Trang 87-97.e5 - 2020
Somedeb Ball1, Avash Das2, Wasawat Vutthikraivit1, Peggy J. Edwards3, Fred Hardwicke4, Nicholas J. Short5, Gautam Borthakur5, Abhishek Maiti6
1Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX
2Department of Molecular Genetics, Graduate School of Biomedical Sciences, University of Texas Southwestern Medical Center, Dallas, TX
3Library, Texas Tech University Health Sciences Center, Lubbock, TX
4Division of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
6Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Clinical Lymphoma, Myeloma and Leukemia

Tập 20

87-97.e5

Thông tin tác giả